Publications by authors named "Magda Altinok"

Claim this Profile
E
Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Magda Lambaa Altinok, Pernille Ravn, Marianne Andersen, Dorte Glintborg

Gynecol Endocrinol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS.
Dorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, Kurt Bjerregaard Stage, Kurt Højlund

Endocr Connect· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
Hanne Mumm, Magda Lambaa Altinok, Jan Erik Henriksen, Pernille Ravn, Dorte Glintborg

Hum Reprod· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
Dorte Glintborg, Johannes J Sidelmann, Magda Lambaa Altinok, Hanne Mumm, Marianne Andersen

Metabolism· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total testosterone levels are often more than three times elevated in patients with androgen-secreting tumours.
Dorte Glintborg, Magda L Altinok, Kresten R Petersen, Pernille Ravn

BMJ Case Rep· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Dorte Glintborg, Magda Altinok, Hanne Mumm, Kristian Buch, Pernille Ravn

Hum Reprod· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
Dorte Glintborg, Hanne Mumm, Magda Lambaa Altinok, Bjørn Richelsen, Jens Meldgaard Bruun

J Endocrinol Invest· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
Dorte Glintborg, Magda Lambaa Altinok, Hanne Mumm, Anne Pernille Hermann, Pernille Ravn

J Clin Endocrinol Metab· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.
Mette B Eriksen, Klaus Brusgaard, Marianne Andersen, Qihua Tan, Magda L Altinok

Eur J Obstet Gynecol Reprod Biol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis